Further information in respect of restatement disclosed in Trading Statement Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Company”) Further information in respect of restatement disclosed in Trading Statement Shareholders are referred to the trading statement released by the Company on 8 March 2019 in terms of which the Company advised shareholders as to an expected range for the earnings per share and headline earnings per share for the six months ended 31 December 2018 (“Trading Statement”). In the Trading Statement, the Company has also disclosed further information in respect of the restatement of its financial results. Shareholders are advised that the restatement in respect of the earnings per share and headline earnings per share attributable to total operations, was as a result of an intercompany profit in inventory (amounting to R25.5 million) not having been eliminated on consolidation in the interim financial results in respect of the six months ended 31 December 2017. Cost of sales and inventory as at 31 December 2017 have therefore been restated in terms of IAS 8. The aforementioned restatement resulted in a decrease in basic and diluted earnings per share of 5.5 cents. All intercompany profit in respect of inventory eliminations have already been recorded for the year ended 30 June 2018. Further information in respect of the aforementioned restatement will be contained in the interim financial results of the Company for the period ended 31 December 2018 which will be released on SENS on Monday, 18 March 2019. Bryanston 15 March 2019 Sponsor Questco Corporate Advisory Proprietary Limited Date: 15/03/2019 03:43:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.